2659 — Shanghai Bao Pharmaceuticals Co Balance Sheet
0.000.00%
Last trade - 00:00- HK$32.37bn
- HK$32.14bn
- CNY6.16m
Annual balance sheet for Shanghai Bao Pharmaceuticals Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Cash and Short Term Investments | 322 | 524 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 30.6 | 44 |
| Total Inventory | ||
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 366 | 666 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 587 | 678 |
| Net Intangible Assets | ||
| Long Term Investments | ||
| Total Assets | 974 | 1,363 |
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Current Portion of Long Term Debt / Capital Leases | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 147 | 196 |
| Long Term Debt | ||
| Capital Lease Obligations | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Deferred Income Tax | ||
| Total Other Liabilities | ||
| Total Liabilities | 225 | 367 |
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Total Equity | 749 | 996 |
| Total Liabilities & Shareholders' Equity | 974 | 1,363 |
| Total Common Shares Outstanding |